The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Antonio La Marca

Mother-Infant Department

Institute of Obstetrics and Gynecology

University of Modena and Reggio Emilia

41100

Italy

[email]@libero.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Mother-Infant Department, Institute of Obstetrics and Gynecology, University of Modena and Reggio Emilia, 41100, Italy. 2007 - 2013

References

  1. Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count. La Marca, A., Grisendi, V., Giulini, S., Argento, C., Tirelli, A., Dondi, G., Papaleo, E., Volpe, A. J. Ovarian. Res (2013) [Pubmed]
  2. Normal serum anti-Müllerian hormone levels in the general female population and the relationship with reproductive history. La Marca, A., Spada, E., Grisendi, V., Argento, C., Papaleo, E., Milani, S., Volpe, A. Eur. J. Obstet. Gynecol. Reprod. Biol. (2012) [Pubmed]
  3. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. La Marca, A., Papaleo, E., Grisendi, V., Argento, C., Giulini, S., Volpe, A. BJOG (2012) [Pubmed]
  4. Possibilities and Limits of Ovarian Reserve Testing in ART. La Marca, A., Argento, C., Sighinolfi, G., Grisendi, V., Carbone, M., D'Ippolito, G., Artenisio, A.C., Stabile, G., Volpe, A. Curr. Pharm. Biotechnol (2011) [Pubmed]
  5. Anti-Müllerian hormone-based prediction model for a live birth in assisted reproduction. La Marca, A., Nelson, S.M., Sighinolfi, G., Manno, M., Baraldi, E., Roli, L., Xella, S., Marsella, T., Tagliasacchi, D., D'Amico, R., Volpe, A. Reprod. Biomed. Online (2011) [Pubmed]
  6. Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. La Marca, A., Spada, E., Sighinolfi, G., Argento, C., Tirelli, A., Giulini, S., Milani, S., Volpe, A. Fertil. Steril. (2011) [Pubmed]
  7. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A.C., Stabile, G., Volpe, A. Hum. Reprod. Update (2010) [Pubmed]
  8. Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. La Marca, A., Sighinolfi, G., Giulini, S., Traglia, M., Argento, C., Sala, C., Masciullo, C., Volpe, A., Toniolo, D. Reprod. Biomed. Online (2010) [Pubmed]
  9. Anti-Mullerian hormone (AMH): what do we still need to know? La Marca, A., Broekmans, F.J., Volpe, A., Fauser, B.C., Macklon, N.S. Hum. Reprod. (2009) [Pubmed]
  10. The Anti-Mullerian hormone and ovarian cancer. La Marca, A., Volpe, A. Hum. Reprod. Update (2007) [Pubmed]
  11. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. La Marca, A., Giulini, S., Tirelli, A., Bertucci, E., Marsella, T., Xella, S., Volpe, A. Hum. Reprod. (2007) [Pubmed]
 
WikiGenes - Universities